Johnson & Johnson JNJ
$269.99
-0.09%
at last close
Market Cap$650.65 billion
P/E Ratio31.32
Div Yield1.99%
Volume16.43M
52-Week Range
$173.33$281.07
Analyst Ratings
- Consensus
- Moderate Buy — 12 Buy · 7 Hold · 0 Sell (19 analysts)
- Avg. Price Target
- $267.84 (-0.8% downside)
Key Stats
- Today's Range
- $267.20 – $272.11
- 50-Day Range
- $245.49 – $281.07
- 52-Week Range
- $173.33 – $281.07
- Volume
- 16.43 million shs
- Average Volume
- 6.47 million shs
- Market Cap
- $650.65 billion
- P/E Ratio
- 31.32
- Dividend Yield
- 1.99%
Valuation
- P/E Ratio
- 31.32
- Price / Book
- 7.66
- Price / Sales
- 6.64
Dividend
- Dividend Yield
- 1.99%
- Annual Dividend
- $5.36
- Payout Ratio
- 62.18%
- Ex-Dividend Date
- 2026-08-25
Short Interest
- Short Interest
- 0.67%
- Days to Cover
- 3.33
Financials (TTM)
- Revenue
- $97.93 billion
- Net Income
- $21.04 billion
- Net Margin
- 21.48%
- Return on Equity
- 24.76%
- Debt-to-Equity
- —
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Related Stocks
Compare head-to-head: JNJ vs LLY·JNJ vs ABBV·JNJ vs ABT·JNJ vs PFE
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.